GW0742

GW0742 (also known as GW610742 and fitorine) is a PPARδ/β agonist that has been investigated for drug use by GlaxoSmithKline.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

GW0742 (also known as GW610742 and fitorine) is a PPARδ/β agonist that has been investigated for drug use by GlaxoSmithKline.

Pharmacodynamics

It is mixed PPAR-B agonist antagonist depending on its dosage. It has weak activity on multiple nuclear receptors as well. It is antagonistic at androgen receptors and VDR. In silico modelling suggest that it has effects on thyroid hormone receptors.

Derivatives

Multiple derivatives of GW0742 core structure have been developed. One of the compounds has the thiazole ring replaced with an oxazole ring inhibited VDR-meditated transcription with IC 50 of 660 nM. Other novel analogues which are more potent than GWO742 with reduced toxicity have been developed as well.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1370308562 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

2 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.